Quantum mechanical-based strategies in drug discovery
By Tiziana Ginex and Fernando Martin The ever-increasing accessible chemical space opens the door to the search for new chemical matter for
By Tiziana Ginex and Fernando Martin The ever-increasing accessible chemical space opens the door to the search for new chemical matter for
Barcelona, Leiden and Uppsala, July 2nd 2024 – Pharmacelera, the leading provider of computational tools for hit discovery, the Leiden Academic Center
San Diego and Barcelona. May 21st 2024. Pharmacelera, a deep tech company that develops and applies accurate Quantum Mechanics and Artificial Intelligence
Barcelona, Spain, and Kyiv, Ukraine, 07 May 2024. Pharmacelera, the leading provider of computational tools for hit discovery, and Enamine, the developer
The application of ligand-based virtual screening (LBVS) is commonly extended in the screening of vast chemical libraries to find novel chemical matter
The technology behind a software is important, but so is how to access it. The user interface (UI) allows users to effectively
For some computational and medicinal chemists, a good graphical user interface (GUI) is essential. It makes it easier to analyze, understand and
We are pleased to announce a new update of our Pharmacelera KNIME nodes. Access to our tools is enhanced with the update
Ligand-based virtual screening is a well-known technique to find hits in the early stages of a drug discovery program. In ligand-based tools,
Commercial chemical libraries have witnessed remarkable growth in recent years, resulting in an unprecedented increase in size and diversity. With advancements in
Ligand-based virtual screening is essential in modern drug discovery workflows and PharmScreen® has been shown to find novel molecules through its unique
3D quantum-mechanics, molecular descriptors, and artificial intelligence provide unique capabilities in the chemical space to identify and qualify novel hits PALO ALTO,
An exponential growth of the accessible chemical space In the last years, there has been an exponential growth in commercial chemical libraries
Barcelona and Uppsala, March 2nd, 2023 – Pharmacelera, the leading provider of computational tools for hit discovery, and MODSIM Pharma AB, the
Barcelona, January 27th, 2023 – Pharmacelera, the leading provider of computational tools for hit discovery, and Welab, the leading drug discovery and
Barcelona, Spain, and Kyiv, Ukraine, 15 December 2022. Pharmacelera, the leading provider of computational tools for hit discovery, and Enamine, the developer
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Privacy & Cookies policy